Dorsomorphin (Compound C): Unraveling AMPK and BMP Signaling in Mitochondrial Quality and Iron Metabolism

Introduction: Beyond Dual-Pathway Modulation

Dorsomorphin, also known as Compound C, has emerged as a pivotal tool in dissecting cellular energy sensing and differentiation pathways. As a highly selective ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) and a potent BMP signaling inhibitor, Dorsomorphin is widely used in research spanning metabolic regulation, autophagy, cancer biology, and neural stem cell differentiation. However, recent advances have illuminated Dorsomorphin’s unique capacity to influence mitochondrial quality control and systemic iron metabolism, adding new dimensions to its application in metabolic and translational research.

Mechanism of Action of Dorsomorphin (Compound C)

AMPK Inhibition: Precision Control Over Cellular Energy Sensing

Dorsomorphin (Compound C) is a cell-permeable, reversible inhibitor that binds competitively at the ATP-binding site of AMPK, with a Ki of 109 nM. This high selectivity over related kinases such as protein kinase A, protein kinase C, and Janus kinase 3 enables precise inhibition of AMPK signaling in diverse cellular systems. The compound suppresses key downstream phosphorylation events, most notably acetyl-CoA carboxylase (ACC) phosphorylation—an essential step in fatty acid metabolism—with approximately 80% reduction in experimental models.

By inhibiting AMPK activity in hepatocytes and other cell types, Dorsomorphin directly impacts autophagy regulation. AMPK is a master regulator of energy homeostasis, and its inhibition curtails autophagic proteolysis, thus affecting cellular adaptation to metabolic stress and nutrient deprivation. This property positions Dorsomorphin as an indispensable tool for elucidating the AMPK signaling pathway’s role in metabolic diseases and cell survival.

BMP/Smad Signaling Inhibition and Its Downstream Effects

Dorsomorphin also potently inhibits bone morphogenetic protein (BMP) signaling by blocking phosphorylation of Smad 1/5/8, a critical step in the BMP/Smad signaling pathway. This dual action distinguishes Dorsomorphin from other kinase inhibitors, enabling researchers to study the intersection of metabolic and developmental pathways. Notably, Dorsomorphin reduces BMP4-induced SMAD phosphorylation with an IC₅₀ of 0.47 μM and attenuates heterotopic ossification and hepatic hepcidin transcription, leading to increased serum iron levels. These effects have direct implications for models of iron metabolism modulation, osteogenesis, and organ-specific differentiation.

Integrating Mitochondrial Quality Control: The AMPK/PINK1/Parkin Axis

Recent literature has expanded our understanding of how Dorsomorphin’s inhibition of AMPK activity influences mitochondrial dynamics and quality control. A landmark study (Ren et al., 2025) demonstrated that AMPK activation is critical for PINK1/Parkin-mediated mitophagy, a selective form of autophagy that maintains mitochondrial homeostasis. In this context, Dorsomorphin’s ability to block AMPK activity provides a powerful approach for delineating the causal relationship between energy sensing, mitochondrial turnover, and skeletal muscle integrity.

In their investigation, Ren and colleagues showed that administration of Lycium barbarum polysaccharide (LBP) ameliorated high-fat-diet-induced skeletal muscle atrophy via activation of the AMPK/PINK1/Parkin pathway. Importantly, these beneficial effects were abrogated by co-administration of Dorsomorphin, confirming that AMPK activity is indispensable for mitophagy-driven mitochondrial repair. This mechanistic insight positions Dorsomorphin as a key negative control in studies of metabolic disease, sarcopenic obesity, and mitochondrial function.

Differentiating Dorsomorphin’s Role: Novel Applications and Insights

Expanding Beyond Muscle Atrophy Models

While previous articles, such as this analysis on mitochondrial quality control and skeletal muscle metabolism, have focused on Dorsomorphin’s relevance in muscle atrophy and autophagy, this article uniquely synthesizes its impact on both mitochondrial dynamics and systemic iron regulation. By integrating recent evidence from AMPK/PINK1/Parkin-mediated mitophagy and hepcidin gene suppression, we provide a comprehensive framework for deploying Dorsomorphin in complex metabolic studies where energy homeostasis, autophagy, and iron handling intersect.

Neural Stem Cell Differentiation and Regenerative Medicine

Dorsomorphin’s inhibition of BMP signaling has profound implications for neural induction and the maintenance of pluripotency in human embryonic stem cells. By blocking SMAD 1/5/8 phosphorylation, Dorsomorphin promotes self-renewal and neural lineage commitment, making it a valuable reagent in protocols aiming to generate neural progenitors or model neurodevelopmental disorders. The compound’s dual action—suppressing both metabolic and developmental pathways—offers unique advantages in studies at the frontiers of regenerative medicine and cellular reprogramming.

Iron Metabolism Modulation in Disease Models

A less-explored, yet increasingly relevant, application of Dorsomorphin is its impact on hepatic hepcidin expression and iron metabolism. By inhibiting BMP/Smad signaling, Dorsomorphin decreases hepcidin transcription, resulting in increased serum iron. This property is particularly valuable in elucidating the crosstalk between metabolic stress, inflammatory signaling, and iron handling in liver disease, anemia of inflammation, and systemic metabolic disorders.

Comparative Analysis with Alternative Methods and Approaches

Most existing resources, such as in-depth mechanistic surveys of Dorsomorphin’s roles in metabolic regulation and thought-leadership pieces on translational strategy, emphasize dual-pathway inhibition and translational applications. Our analysis differentiates itself by emphasizing the integrative role of Dorsomorphin in mitochondrial quality control and iron metabolism, synthesizing these processes as interconnected rather than isolated effects. This holistic approach enables researchers to design experiments that probe the systemic consequences of AMPK and BMP pathway inhibition, rather than focusing solely on cell-autonomous endpoints.

Alternative AMPK inhibitors, such as AICAR or metformin, have broader off-target effects and lack the reversible, ATP-competitive specificity provided by Dorsomorphin (Compound C). Similarly, BMP pathway inhibitors like LDN-193189 may not recapitulate the full spectrum of metabolic and developmental modulation achieved by Dorsomorphin’s dual inhibitory action. This makes Dorsomorphin uniquely suited for dissecting crosstalk between energy metabolism, autophagy, differentiation, and iron handling.

Best Practices: Experimental Protocols and Handling

Dorsomorphin is supplied as a solid, insoluble in water and ethanol, but readily dissolves in DMSO (≥8.49 mg/mL) with gentle warming and ultrasonic treatment. For optimal results, researchers should prepare fresh solutions prior to use, as solutions are not recommended for long-term storage. The recommended concentration for cell culture applications is 4–40 μM, while 10 mg/kg via intraperitoneal injection is advised for animal models. Storage at -20°C is essential to maintain compound integrity.

Experimental designs should incorporate appropriate controls to distinguish the effects of AMPK inhibition from BMP/Smad pathway blockade. For studies of autophagy regulation, inclusion of additional mitophagy modulators or genetic models (e.g., Parkin knockdown) is recommended to parse out pathway-specific effects, as elegantly demonstrated in the recent AMPK/PINK1/Parkin mitophagy study (Ren et al., 2025).

Advanced Applications: From Cancer Research to Metabolic Disease

Cancer Research: Metabolic and Differentiation Pathways

Dorsomorphin’s dual inhibition of the AMPK and BMP pathways is increasingly leveraged in cancer research to interrogate metabolic reprogramming, tumor cell survival, and invasion. By modulating both energy homeostasis (via AMPK) and differentiation cues (via BMP/Smad), Dorsomorphin enables multi-layered analysis of tumorigenesis, particularly in metabolic cancers and those exhibiting aberrant BMP signaling.

Metabolic Disease and Sarcopenic Obesity Models

The insights from the Ren et al. study (2025) underscore the necessity of AMPK-mediated mitophagy for maintaining muscle mass in the context of high-fat diet-induced sarcopenic obesity. Dorsomorphin serves as an essential pharmacological tool for validating the role of AMPK in mitophagy, mitochondrial dynamics, and proteostasis. By integrating Dorsomorphin into these models, researchers can delineate the contribution of energy-sensing pathways to muscle atrophy and systemic metabolic dysfunction.

Neural Stem Cell Differentiation and Disease Modeling

In neural lineage studies, Dorsomorphin’s capacity to inhibit BMP signaling and promote neural induction is exploited to generate homogeneous populations of neural progenitors from pluripotent stem cells. This enables high-fidelity modeling of neurodevelopmental disorders and the development of regenerative therapies targeting CNS injuries and neurodegeneration.

Conclusion and Future Outlook

Dorsomorphin (Compound C) stands at the intersection of metabolic, developmental, and disease biology, offering unparalleled specificity and versatility for advanced research. By leveraging its ATP-competitive AMPK inhibition and BMP/Smad pathway blockade, investigators can interrogate the molecular underpinnings of mitochondrial quality control, autophagy regulation, iron metabolism modulation, and cellular differentiation. The integration of recent findings—such as those on AMPK/PINK1/Parkin-mediated mitophagy and systemic iron handling—positions Dorsomorphin as a cornerstone reagent for next-generation translational and mechanistic studies.

For researchers seeking to design experiments at the frontier of metabolic disease, muscle atrophy, cancer biology, or regenerative medicine, Dorsomorphin (Compound C) (SKU: B3252) provides the precision and reliability required to unravel complex biological networks. By building upon and extending the insights from previous analyses—such as the protocol-focused guides (see here) and translational strategy discussions (see here)—this article offers a holistic and integrative perspective, empowering researchers to advance discovery across metabolic and developmental biology.